Cargando…
Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence
BACKGROUND: Effective response to emerging pandemic threats is complicated by the need to develop specific vaccines and other medical products. The availability of broadly specific countermeasures that could be deployed early in the pandemic could significantly alter its course and save countless li...
Autores principales: | Yagovkina, Nadezhda V., Zheleznov, Lev M., Subbotina, Ksenia A., Tsaan, Andrey A., Kozlovskaya, Liubov I., Gordeychuk, Ilya V., Korduban, Anastasia K., Ivin, Yury Y., Kovpak, Anastasia A., Piniaeva, Anastasia N., Shishova, Anna A., Shustova, Elena Y., Khapchaev, Yusuf K., Karganova, Galina G., Siniugina, Alexandra A., Pomaskina, Tatiana V., Erovichenkov, Aleksandr A., Chumakov, Konstantin, Ishmukhametov, Aydar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196174/ https://www.ncbi.nlm.nih.gov/pubmed/35711442 http://dx.doi.org/10.3389/fimmu.2022.907341 |
Ejemplares similares
-
Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II
por: Piniaeva, Anastasia, et al.
Publicado: (2021) -
Corrigendum to isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak [Int. J. Infect. Dis. 99 (2020) 40-46]
por: Kozlovskaya, Liubov, et al.
Publicado: (2021) -
Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak
por: Kozlovskaya, Liubov, et al.
Publicado: (2020) -
Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts
por: Gordeychuk, Ilya V., et al.
Publicado: (2023) -
Methodology of Purification of Inactivated Cell-Culture-Grown SARS-CoV-2 Using Size-Exclusion Chromatography
por: Kovpak, Anastasia A., et al.
Publicado: (2022)